Trevi Therapeutics, Inc.
TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA

Abstract:

The present invention relates to methods for treating patients with chronic cough with nalbuphine compositions as well as treating cough, breathlessness, or dyspnea associated with IPF with nalbuphine compositions, wherein the method provides a therapeutic effect in a patient.